학술논문

In-class transition from bortezomib-based therapy to IRd is an effective approach in newly diagnosed multiple myeloma
Document Type
Article
Source
In: Future Oncology. (Future Oncology, 1 January 2024, 20(3):131-143)
Subject
Language
English
ISSN
17448301
14796694